Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Safety of infliximab treatment in pediatric patients with inflammatory bowel disease.

Friesen CA, Calabro C, Christenson K, Carpenter E, Welchert E, Daniel JF, Haslag S, Roberts CC.

J Pediatr Gastroenterol Nutr. 2004 Sep;39(3):265-9.

PMID:
15319627
[PubMed - indexed for MEDLINE]
2.

Review article: Infliximab therapy for inflammatory bowel disease--seven years on.

Rutgeerts P, Van Assche G, Vermeire S.

Aliment Pharmacol Ther. 2006 Feb 15;23(4):451-63. Review.

PMID:
16441465
[PubMed - indexed for MEDLINE]
Free Article
3.

Infliximab therapy in children and adolescents with inflammatory bowel disease.

Veres G, Baldassano RN, Mamula P.

Drugs. 2007;67(12):1703-23. Review.

PMID:
17683171
[PubMed - indexed for MEDLINE]
4.

Current therapy of inflammatory bowel disease in children.

Rufo PA, Bousvaros A.

Paediatr Drugs. 2006;8(5):279-302. Review.

PMID:
17037946
[PubMed - indexed for MEDLINE]
5.

A review of infliximab use in ulcerative colitis.

Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB.

Clin Ther. 2008 Feb;30(2):223-30. doi: 10.1016/j.clinthera.2008.02.014. Review.

PMID:
18343261
[PubMed - indexed for MEDLINE]
6.

Infliximab use in children and adolescents with inflammatory bowel disease.

de Ridder L, Benninga MA, Taminiau JA, Hommes DW, van Deventer SJ.

J Pediatr Gastroenterol Nutr. 2007 Jul;45(1):3-14. Review.

PMID:
17592358
[PubMed - indexed for MEDLINE]
7.

Review article: safety of infliximab in clinical trials.

Hanauer SB.

Aliment Pharmacol Ther. 1999 Sep;13 Suppl 4:16-22; discussion 38. Review.

PMID:
10597335
[PubMed - indexed for MEDLINE]
Free Article
8.

Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA.

J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74.

PMID:
17460505
[PubMed - indexed for MEDLINE]
9.

Alternative strategies for the use of infliximab in pediatric inflammatory bowel disease.

Rosh JR.

Curr Gastroenterol Rep. 2008 Jun;10(3):302-7. Review.

PMID:
18625142
[PubMed - indexed for MEDLINE]
10.

Infliximab therapy for pediatric Crohn's disease.

Veres G, Baldassano RN, Mamula P.

Expert Opin Biol Ther. 2007 Dec;7(12):1869-80. Review.

PMID:
18034652
[PubMed - indexed for MEDLINE]
11.

Infliximab use in luminal Crohn's disease.

Richter JA, Bickston SJ.

Gastroenterol Clin North Am. 2006 Dec;35(4):775-93. Review.

PMID:
17129813
[PubMed - indexed for MEDLINE]
12.

The therapeutic spectrum of infliximab and tumor necrosis factor immunomodulation in chronic inflammatory diseases.

Ricart E, Bouma G, Peña AS.

Drugs Today (Barc). 2002 Nov;38(11):725-44. Review.

PMID:
12582457
[PubMed - indexed for MEDLINE]
13.

[TNF-alpha inhibitors in inflammatory bowel disease].

Casellas i Jordà F.

Med Clin (Barc). 2004 Nov 6;123(16):627-34. Review. Spanish.

PMID:
15546523
[PubMed - indexed for MEDLINE]
14.

Infliximab in ulcerative colitis.

Aberra FN, Lichtenstein GR.

Gastroenterol Clin North Am. 2006 Dec;35(4):821-36. Review.

PMID:
17129815
[PubMed - indexed for MEDLINE]
15.

Infliximab for pediatric Crohn's disease.

Hoffman I, Vermeire S, Van Assche G, Rutgeerts P.

Drugs Today (Barc). 2008 Aug;44(8):615-28. doi: 10.1358/dot.2008.44.8.1248345. Review.

PMID:
18846272
[PubMed - indexed for MEDLINE]
16.

[Indications and results of infliximab in Crohn's disease].

Karoui S, Boubaker J, Filali A.

Tunis Med. 2004 Dec;82(12):1057-63. Review. French.

PMID:
15822505
[PubMed - indexed for MEDLINE]
17.

Guidelines for treatment with infliximab for Crohn's disease.

Hommes DW, Oldenburg B, van Bodegraven AA, van Hogezand RA, de Jong DJ, Romberg-Camps MJ, van der Woude J, Dijkstra G; Dutch Initiative on Crohn and Colitis (ICC).

Neth J Med. 2006 Jul-Aug;64(7):219-29. Review.

PMID:
16929083
[PubMed - indexed for MEDLINE]
Free Article
18.

The onset of psoriasis during the treatment of inflammatory bowel diseases with infliximab: should biological therapy be suspended?

Denadai R, Teixeira FV, Saad-Hossne R.

Arq Gastroenterol. 2012 Apr-Jun;49(2):172-6. Review.

PMID:
22767007
[PubMed - indexed for MEDLINE]
Free Article
19.

Emerging biologic therapies in inflammatory bowel disease.

Lim WC, Hanauer SB.

Rev Gastroenterol Disord. 2004 Spring;4(2):66-85. Review.

PMID:
15184826
[PubMed - indexed for MEDLINE]
20.

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.

Miehsler W, Novacek G, Wenzl H, Vogelsang H, Knoflach P, Kaser A, Dejaco C, Petritsch W, Kapitan M, Maier H, Graninger W, Tilg H, Reinisch W; Austrian Society of Gastroenterology and Hepatology.

J Crohns Colitis. 2010 Sep;4(3):221-56. doi: 10.1016/j.crohns.2009.12.001. Epub 2010 Mar 17.

PMID:
21122513
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk